Genetic Analysis (GEAN) | Spotlight

Home

Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-: 0.175
%: 8,35%
Latest: 2.27
High: 2.275
Low: 2.07
Volume: 17 817
Turnover (NOK): 38 564
Market Value (MNOK): 56,6
Time (Latest trade): 2022-11-30 11:51

Board

CEO

Ronny Hermansen

Chairperson of the Board

Per Matsson

Board

Andrew Stapleton
Camilla Huse Bondesson
Rune Sørum
Staffan Strömberg

News

2022-11-30 08:00:00 Genetic Analysis AS enters an agreement with Hausen Bernstein Co. Ltd. to launch GA-map[®] technology in Thailand
2022-11-30 08:00:00 Genetic Analysis ingår avtal med Hausen Bernstein om lansering av GA-map[®] i Thailand
2022-11-21 08:00:00 Genetic Analysis AS announces the outcome of the warrant exercise
2022-11-21 08:00:00 Genetic Analysis AS offentliggör utfall i optionsinlösen
2022-11-10 12:33:59 Last day of trading in warrants of series TO 1 is November 14, 2022

Show More

News agencies

2022-11-30 08:23:57 Finwire: Genetic Analysis i avtal med thailändskt bolag avseende lansering av GA-map
2022-11-23 09:08:35 Finwire: Mangold sänker Genetic Analytics riktkurs till 4,5 kronor (5,3)
2022-11-21 08:20:00 Finwire: Genetic Analysis teckningsoptioner av serie TO1 utnyttjades inte
2022-11-07 08:21:27 Finwire: Genetic Analysis ingår europeiskt distributionsavtal för GA-map
2022-11-01 11:26:15 Direkt: LIVE 12.00 - RAPPORTINTERVJU MED VD & CCO

Show More

Analysis

Key Numbers

*Compiled data from Millistream

Upcoming reports

2023-02-17 Bokslutskommuniké 2022

Annual reports, prospectus etc.